LONG-TERM EFFICACY AND SAFETY OF LOW DOSE AND DOSE ESCALATING INTERFERON ALFA-2A THERAPY IN REFRACTORY BEHCET'S UVEITIS

被引：0
|
作者：
Onal, Sumru [1 ]
Kazokoglu, Haluk [1 ]
Koc, Aylin [1 ]
Akman, Mehmet
Bavbek, Tayfun [1 ]
Direskenell, Haner [2 ]
Yavuz, Sule [2 ]
机构：
[1] Univ Marmara, Dept Ophthalmol, Istanbul, Turkey
[2] Univ Marmara, Dept Rheumatol, Istanbul, Turkey
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2010年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [21] Long-Term Efficacy and Safety of Low-Dose Rituximab in Patients with Refractory Myasthenia Gravis
    Ren, Jingru
    Wang, Jianchun
    Liu, Ran
    Jin, Yunyi
    Guo, Jing
    Yao, Yan
    Luo, Jingjing
    Hao, Hongjun
    Gao, Feng
    EUROPEAN NEUROLOGY, 2023, 86 (06) : 387 - 394
  • [22] Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy
    Wietzke-Braun, P
    Meier, V
    Braun, F
    Ramadori, G
    WORLD JOURNAL OF GASTROENTEROLOGY, 2001, 7 (02) : 222 - 227
  • [23] Evaluation of the Long-Term Efficacy and Safety of Infliximab Treatment for Uveitis in Behcet's Disease
    Takeuchi, Masaru
    Kezuka, Takeshi
    Sugita, Sunao
    Keino, Hiroshi
    Namba, Kenichi
    Kaburaki, Toshikatsu
    Maruyama, Kazuichi
    Nakai, Kei
    Hijioka, Kuniaki
    Shibuya, Etsuko
    Komae, Keiko
    Hori, Junko
    Ohguro, Nobuyuki
    Sonoda, Koh-hei
    Mizuki, Nobuhisa
    Okada, Annabelle A.
    Ishibashi, Tatsuro
    Goto, Hiroshi
    Mochizuki, Manabu
    OPHTHALMOLOGY, 2014, 121 (10) : 1877 - 1884
  • [24] Behcet's uveitis in Japan: evaluation of the long-term efficacy and safety of infliximab treatment
    Takeuchi, M.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [25] An unusual axonal polyneuropathy induced by low-dose interferon alfa-2a
    Rutkove, SB
    ARCHIVES OF NEUROLOGY, 1997, 54 (07) : 907 - 908
  • [26] Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behcet's disease
    Katsuyama, Atsuko
    Kusuhara, Sentaro
    Nishisho, Ryuto
    Matsumiya, Wataru
    Azumi, Atsushi
    Nakamura, Makoto
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 521 - 527
  • [27] Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease
    Abu El-Asrar A.M.
    Abboud E.B.
    Aldibhi H.
    Al-Arfaj A.
    International Ophthalmology, 2005, 26 (3) : 83 - 92
  • [28] Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic hepatitis C virus-infected nonresponders and relapsers after interferon alfa-2a monotherapy.
    Wietzke-Braun, P
    Meier, V
    Braun, F
    Ramadori, G
    HEPATOLOGY, 2000, 32 (04) : 353A - 353A
  • [29] LOW-DOSE INTERFERON ALPHA-2A TREATMENT IN REFRACTORY BEHCET UVEITIS: A SINGLE CENTER EXPERIENCE
    Yilmaz, S. G.
    Keser, G.
    Yilmaz, Z.
    Aksu, K.
    Ates, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 927 - 927
  • [30] Efficacy and safety of PEG IFN Alfa-2a and low dose ribavirin in ESRD patients with hepatitis C
    Friedman, Daniel
    Rashdan, Sawsan
    Levine, Cheryl D.
    Weinstein, Jeffrey
    Schwartz, Armond G.
    Tanriover, Bekir
    Ghalib, Reem H.
    GASTROENTEROLOGY, 2007, 132 (04) : A795 - A795
12345